Michael Kyba

Biography

Dr. Michael Kyba is affiliated to Biomaterials, University of Minnesota, where Dr. Michael Kyba is currently working as University of Minnesota. Dr. Michael Kyba has authored and co-authored several national and international publications and also working as a reviewer for reputed professional journals. Dr. Michael Kyba is having an active association with different societies and academies around the world. Dr. Michael Kyba made his mark in the scientific community with the contributions and widely recognition from honourable subject experts around the world. Dr. Michael Kyba has received several awards for the contributions to the scientific community. Dr. Michael Kyba major research interest involves focuses on regulation of tissue-specific stem cells (hematopoietic and skeletal muscle) with a view towards ex-vivo expansion and therapeutic transplantation, as well as the derivation of tissue-specific stem cells from embryonic or iPS cells.. Dr. Michael Kyba is affiliated to Biomaterials, University of Minnesota, where Dr. Michael Kyba is currently working as University of Minnesota. Dr. Michael Kyba has authored and co-authored several national and international publications and also working as a reviewer for reputed professional journals. Dr. Michael Kyba is having an active association with different societies and academies around the world. Dr. Michael Kyba made his mark in the scientific community with the contributions and widely recognition from honourable subject experts around the world. Dr. Michael Kyba has received several awards for the contributions to the scientific community. Dr. Michael Kyba major research interest involves focuses on regulation of tissue-specific stem cells (hematopoietic and skeletal muscle) with a view towards ex-vivo expansion and therapeutic transplantation, as well as the derivation of tissue-specific stem cells from embryonic or iPS cells..

Research Interest

focuses on regulation of tissue-specific stem cells (hematopoietic and skeletal muscle) with a view towards ex-vivo expansion and therapeutic transplantation, as well as the derivation of tissue-specific stem cells from embryonic or iPS cells.